Maternal-to-zygotic transition as a potential target for niclosamide during early embryogenesis.
Sign Up to like & getrecommendations! Published in 2019 at "Toxicology and applied pharmacology"
DOI: 10.1016/j.taap.2019.114699
Abstract: Niclosamide is an antihelminthic drug used worldwide for the treatment of tapeworm infections. Recent drug repurposing screens have highlighted the broad bioactivity of niclosamide across diverse mechanisms of action. As a result, niclosamide is being… read more here.
Keywords: target niclosamide; embryogenesis; maternal zygotic; zygotic transition ... See more keywords